AAAAAA

   
Results: 1-3 |
Results: 3
Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin
Authors: Wong, MT Kauffman, CA Standiford, HC Linden, P Fort, G Fuchs, HJ Porter, SB Wenzel, RP
Citation: Mt. Wong et al., Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin, CLIN INF D, 33(9), 2001, pp. 1476-1482
Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention - Emory workshop
Authors: Howard, D Cordell, R McGowan, JE Packard, RM Scott, RD Solomon, SL Elbasha, EH Gerberding, JL Meltzer, MI Weber, JT Rajbhandary, S Steinberg, JP Flanders, WD Florence, CS Roberts, R Weinstein, RA Goss, TF Song, XY Roghmann, MC Bradham, DD South, BR Bellm, LA Mulligan, MLE Porter, SB Teutsch, S Callahan, M Saint, S Rosenman, R Fraser, VJ
Citation: D. Howard et al., Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention - Emory workshop, CLIN INF D, 33(9), 2001, pp. 1573-1578
A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS
Authors: Holodniy, M Koch, J Mistal, M Schmidt, JM Khandwala, A Pennington, JE Porter, SB
Citation: M. Holodniy et al., A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS, AM J GASTRO, 94(11), 1999, pp. 3267-3273
Risultati: 1-3 |